Anti-PD-1 Therapy Plus Chemotherapy And/or Bevacizumab As Second Line or Later Treatment for Patients with Advanced Non-Small Cell Lung Cancer.
Journal of cancer（2020）
Key words
immune checkpoint inhibitor,combination therapy,non-small cell lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined